News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,609 Results
Type
Article (14432)
Company Profile (281)
Press Release (256896)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (80543)
Career Advice (155)
Deals (13337)
Drug Delivery (35)
Drug Development (50602)
Employer Resources (31)
FDA (5809)
Job Trends (5245)
News (145929)
Policy (10257)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (931)
Accelerated approval (2)
Adcomms (12)
Allergies (53)
Alliances (21922)
ALS (63)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (98)
Approvals (5834)
Artificial intelligence (123)
Autoimmune disease (18)
Automation (5)
Bankruptcy (111)
Best Places to Work (4666)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (51)
Brain cancer (20)
Breast cancer (151)
Cancer (1416)
Cardiovascular disease (116)
Career advice (135)
Career pathing (2)
CAR-T (113)
Cell therapy (318)
Cervical cancer (8)
Clinical research (41129)
Collaboration (534)
Compensation (256)
Complete response letters (13)
COVID-19 (1054)
CRISPR (39)
C-suite (158)
Cystic fibrosis (76)
Data (1456)
Denatured (11)
Depression (29)
Diabetes (135)
Diagnostics (1348)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (89)
Earnings (30091)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48799)
Executive appointments (453)
FDA (6494)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (93)
Generative AI (10)
Gene therapy (242)
GLP-1 (364)
Government (1119)
Grass and pollen (2)
Guidances (21)
Healthcare (6832)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (89)
Indications (20)
Infectious disease (1119)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (64)
Interviews (19)
IPO (7322)
IRA (11)
Job creations (866)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1463)
Liver cancer (31)
Lung cancer (201)
Lymphoma (96)
Machine learning (3)
Management (7)
Manufacturing (138)
MASH (52)
Medical device (2770)
Medtech (2771)
Mergers & acquisitions (6336)
Metabolic disorders (385)
Multiple sclerosis (52)
NASH (13)
Neurodegenerative disease (64)
Neuropsychiatric disorders (25)
Neuroscience (1244)
NextGen: Class of 2025 (2107)
Non-profit (963)
Northern California (1663)
Now hiring (22)
Obesity (193)
Opinion (105)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (54)
Parkinson's disease (119)
Partnered (8)
Patents (126)
Patient recruitment (73)
Peanut (35)
People (25957)
Pharmaceutical (47)
Pharmacy benefit managers (6)
Phase I (14521)
Phase II (19120)
Phase III (12106)
Pipeline (788)
Policy (47)
Postmarket research (856)
Preclinical (6110)
Press Release (30)
Prostate cancer (59)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (287)
Real estate (1437)
Recruiting (12)
Regulatory (8736)
Reports (15)
Research institute (951)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (58)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1455)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1983)
State (1)
Stomach cancer (4)
Supply chain (22)
Tariffs (6)
The Weekly (36)
United States (12990)
Vaccines (213)
Venture capitalists (32)
Weight loss (109)
Women's health (17)
Worklife (2)
Date
Today (68)
Last 7 days (336)
Last 30 days (1431)
Last 365 days (19594)
2025 (5843)
2024 (20661)
2023 (22602)
2022 (27053)
2021 (28073)
2020 (23848)
2019 (16684)
2018 (12109)
2017 (13920)
2016 (12041)
2015 (14488)
2014 (10508)
2013 (7555)
2012 (7622)
2011 (7732)
2010 (7523)
Location
Africa (150)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17395)
Australia (2954)
California (3779)
Canada (1120)
China (345)
Colorado (146)
Connecticut (149)
Delaware (97)
Europe (37508)
Florida (459)
Georgia (115)
Idaho (16)
Illinois (241)
India (10)
Indiana (91)
Iowa (1)
Japan (73)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (12)
Maryland (466)
Massachusetts (2985)
Michigan (70)
Minnesota (146)
Mississippi (1)
Missouri (29)
Montana (14)
Nebraska (5)
Nevada (17)
New Hampshire (14)
New Jersey (942)
New Mexico (12)
New York (1020)
North Carolina (542)
North Dakota (4)
Northern California (1663)
Ohio (111)
Oklahoma (9)
Oregon (21)
Pennsylvania (722)
Puerto Rico (5)
Rhode Island (18)
South America (227)
South Carolina (4)
Southern California (1455)
Tennessee (25)
Texas (437)
Utah (55)
Virginia (77)
Washington D.C. (30)
Washington State (344)
Wisconsin (14)
271,609 Results for "shield therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA
April 16, 2025
·
7 min read
Press Releases
Innovative Startups Developing Next-Gen Cancer Treatments and Radiation-Shielding Material Selected Through MassChallenge Accelerator for Space-Based Research
April 11, 2025
·
5 min read
Genetown
Cimeio Therapeutics Announces Publication in Nature Demonstrating That CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
Cimeio Therapeutics today announced a publication in Nature showing that its CD45 antibody-drug conjugate (ADC) eradicated aggressive leukemic cells in vivo, while hematopoiesis was fully preserved and protected from the ADC via shielded hematopoietic stem cells (HSCs).
May 22, 2024
·
3 min read
Press Releases
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
March 11, 2025
·
6 min read
Press Releases
Guardant Health’s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program
January 30, 2025
·
4 min read
Business
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
Teva Pharmaceutical Industries Ltd. today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024.
May 15, 2024
·
7 min read
Press Releases
Radiation Shield Technologies Demron Shields High Energy Beta Radiation by 91%
August 20, 2024
·
2 min read
Genetown
Cimeio Therapeutics Presents Data for its CD52 Shielding Variant at ASGCT
Cimeio Therapeutics is presenting data for its CD52 program during this week’s Annual Meeting of the American Society of Cell & Gene Therapy (ASGCT) in Baltimore.
May 9, 2024
·
2 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
BioMidwest
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
NeurAxis, Inc., a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced receipt of Blue Cross and Blue Shield of Kansas City policy coverage for approximately one million lives.
March 4, 2024
·
3 min read
1 of 27,161
Next
